- WBPaper00061530:nhr-49(e2144)_upregulated
Fold change > 2, p Value of < 0.05 and a false discovery rate (FDR) of < 0.05.
Transcripts that showed significantly increased expression in AGP22 [nhr-49(nr2041)I;glp-1(e2141)III] comparing to in CF1903 [glp-1(e2144)III] at Day 2 adults.
- WBPaper00061530:nhr-49(e2144)_downregulated
Fold change > 2, p Value of < 0.05 and a false discovery rate (FDR) of < 0.05.
Transcripts that showed significantly decreased expression in AGP22 [nhr-49(nr2041)I;glp-1(e2141)III] comparing to in CF1903 [glp-1(e2144)III] at Day 2 adults.
- WBPaper00065623:49
CellRanger, DecontX, Monocle3, Louvain algorithm.
Single-cell RNA-Seq cell group 49 expressed in: SIA.
- WBPaper00056073:R24_upregulated_nhr-86_dependent
N.A.
Transcripts that were induced after treatment by immunostimulatory xenobiotic R24 (a.k.a RPW-24, 2-N-(3-Chloro-4-methylphenyl)quinazoline-2,4-diamine)), and the induction level was altered in nhr-86(tm2590) and nhr-86(ums12) animals.
- WBPaper00042194:nhr-114(RNAi)_upregulated
Differentially expressed genes had a fold change cutoff of 2.0 and an unpaired t test p value cutoff of 0.05 for WT+Trp versus WT and 0.01 for nhr-114 versus glp-1.
Genes up regulated in nhr-114(RNAi) comparing to glp-1(q224ts).